Bacterial invasin: Structure, function, and implication for targeted oral gene delivery

Current Drug Delivery

Volumn 3, Issue 1, 2006, Pages 47-53

  Palumbo, R Noelle ^a   Wang, Chun ^a  

^a University of Minnesota   (United States)

Author keywords

Bacterial invasin; Integrin receptor; M cell; Microparticle; Nanoparticle; Oral gene delivery; Vaccine delivery

Indexed keywords

BACTERIAL PROTEIN; BETA1 INTEGRIN; CHITOSAN; DRUG CARRIER; INTEGRIN RECEPTOR; INVASIN; POLYANHYDRIDE; POLYGLACTIN; POLYSTYRENE; ADHESIN; INVASIN, YERSINIA; VERY LATE ACTIVATION ANTIGEN;

CELL INVASION; EPITHELIUM CELL; GENE DELIVERY SYSTEM; GENE TARGETING; GENE THERAPY; HUMAN; IMMUNE RESPONSE; M CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; REVIEW; YERSINIA; ANIMAL; CHEMISTRY; CYTOLOGY; DRUG DELIVERY SYSTEM; GENE TRANSFER; INTESTINE MUCOSA; METABOLISM; METHODOLOGY; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; PATHOGENICITY;

ADHESINS, BACTERIAL; ADMINISTRATION, ORAL; ANIMALS; DRUG DELIVERY SYSTEMS; EPITHELIAL CELLS; GENE THERAPY; GENE TRANSFER TECHNIQUES; INTESTINAL MUCOSA; RECEPTORS, VERY LATE ANTIGEN; YERSINIA;

EID: 33644985324     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720106775197475     Document Type: Review

References (66)

1. Neutra, M.R.; Frey, A.; Kraehenbuhl, J.P. Cell, 1996, 86(3), 345-348.
2. Jang, M.H.; Kweon, M.N,; Iwatani, K.; Yamamoto, M.; Terahara, K.; Sasakawa, C.; Suzuki, T.; Nochi, T.; Yokota, Y.; Rennert, P.D.; Hiroi, T.; Tamagawa, H.; Iijima, H.; Kunisawa, J.; Yuki, Y.; Kiyono, H. Proc. Nat. Acad. Sci. USA, 2004, 101(16), 6110-6115.
3. Clark, A.M.; Hirst, B.H.; Jepson, M.A. Infect. Immun., 1998, 66(3), 1237-1243.
4. Isberg, R.R.; Tran Van Nhieu, G. Annu. Rev. Genet., 1994, 27, 395-422.
5. Cossart, P. J. Clin. Invest., 1997, 99(10), 2307-2311.
6. Grassl, G.A.; Bohn, E.; Müller, Y.; Bühler, O.T.; Autenrieth, I.B. Int. J. Med. Microbiol., 2003, 293, 41-54.
7. Isberg, R.R.; Voorhis, D.L.; Falkow, S. Cell, 1987, 50, 769-778.
8. Pepe, J.C.; Miller,V.L. Proc. Natl. Acad. Sci. USA, 1993, 90, 6473-6477.
9. Marra, A.; Isberg, R.R. Infect. Immun., 1997, 65(8), 3412-3421.
10. Isberg, R.R.; Leong, J.M. Cell, 1990, 60, 861-871.
11. Isberg, R.R.; Tran Van Nhieu, G. Trends in Microbiology, 1994, 2(1), 10-14.
12. Schulte, R.; Kerneis, S.; Klinke, S.; Barteis, H.; Preger, S.; Kraehenbuhl, J.P.; Pringault, E.; Autenrieth, I.B. Cell Microbiol., 2000, 2(2), 173-185.
13. Tran Van Nhieu, G.; Krukonis, E.S.; Reszka, A.A.; Horwitz, A.F.; Isberg, R.R. J. Biol. Chem., 1996, 271(13), 7665-7672.
14. Ménard, R.; Prévost, M.C.; Gounon, P.; Sansonetti, P.; Dehio, C. Proc. Natl. Acad. Sci. USA, 1996, 93, 1254-1258.
15. Watarai, M.; Funato, S.; Sasakawa, C. J. Exp. Med., 1996, 183, 991-999.
16. Dersch, P.; Isberg, R. Infect. Immun., 2000, 68(5), 2930-2938.
17. Leong, J.M.; Fournier, R.S.; Isberg, R.R. EMBO J., 1990, 9(6), 1979-1989.
18. Hamburger, Z.; Brown, M.S.; Isberg, R.R.; Bjorkman, P.J. Science, 1999, 286(5438), 291-295.
19. Leong, J.M.; Fournier, R.S.; Isberg, R.R. Infect. Immun., 1991, 59(10), 3424-3433.
20. Leong, J.M.;Morrissey, P.E.; Marra, A.; Esberg, R.R. EMBO J., 1995, 4(3), 422-431.
21. Rankin, S.; Isberg, R.R.; Leong, J.M. Infect. Immun., 1992, 60(9), 3909-3912.
22. Saltman, L.H.; Lu, Y.; Zaharias, E.; Isberg, R.R. J. Biol. Chem., 1996, 271(38), 23438-23444.
23. Tran Van Nhieu, G.; Isberg, R. J. Biol. Chem., 1991, 266(36), 24367-24375.
24. Leong, J.M.; Morrissey, P.E.; Isberg R.R. J. Biol. Chem., 1993, 268(27), 20524-20532.
25. Tran Van Nhieu, G.; Isberg, R. EMBO J., 1993, 12(5), 1887-1895.
26. Dersch, P.; Isberg, R.R. EMBO J., 1999, 18, 1199-1213.
27. Hemler, M.E. Annu. Rev. Immunol., 1990, 8, 365-400.
28. Gustavsson, A.; Armulik, A.; Brakebusch, C.; Fässler, R.; Johansson, S.; Fällman, M. J. Cell Science, 2002, 115, 2669-2678.
29. Alrutz, M.; Isberg, R. Proc. Nat. Acad. Sci. USA, 1998, 95(23), 13658-13663.
30. Cossart, P.; Sansonetti, P.J.; Science, 2004, 304(5668), 242-248.
31. Kampik, D.; Schulte, R.; Autenrieth, I.B. Infect. Immun., 2000, 68, 2484-2492.
32. Sansonetti, P. Immunology, 2001, 13, 381-390.
33. Wiedemann, A.; Linder, S.; Grassl, G.; Albert, M.; Autenrieth, I.; Aepfelbacher, M. Cellular Microbiology, 2001, 3(10), 693-702.
34. Lundgren, E.; Carballeira, N.; Vazquez, R.; Dubinina, E.; Brändén, H.; Persson, H.; Wolf-Watz, H. Infect. Immun., 1996, 64(3), 829-835.
35. Arencibia, I.; Suárez, N.C.; Wolf-Watz, H.; Sundqvist, K.G. J. Immunol., 1997, 159, 1853-1859.
36. Monack, D.M.; Mecsas, J.; Bouley, D.; Falkow, S. J. Exp. Med., 1998, 188(11), 2127-2137.
37. Fortunati, E.; Ehlert, E.; van Loo, N.D; Wyman, C.; Eble, J.A; Grosveld, F.; Scholte, B.J. Gene Therapy, 2000, 7, 1505-1515.
38. Paul, R.W.; Weisser, K.E.; Loomis, A.; Sloane, D.; LaFoe, D.; Atkinson, E.M.; Overell, R.W. Human Gene Therapy, 1997, 8, 1253-1262.
39. Critchley, R.J.; Jezzard, S.; Radford, K.J.; Goussard, S.; Lemoine, N.R.; Grillot-Courvalin, C.; Vassaux, G. Gene Therapy, 2004, 11, 1224-1233.
40. Fajac, I.; Grosse, S.; Collombet, J.M.; Thevenot, G.; Goussard, S.; Danel, C.; Grillot-Courvalin, C. J. Controlled Release, 2004, 97(2), 371-381.
41. Grillot-Courvalin, C.; Goussard, S.; Huetz, F.; Ojcius, D.M.; Courvalin, P. Nature Biotechnology, 1998, 16, 862-866.
42. Narayanan, K.; Warburton, P.E. Nucleic Acids Res., 2003, 31(9), e51.
43. Kaneko, H.; Bednarek, I.; Wierzbicki, A.; Kiszka, I.; Dmochowski, M.; Wasik, T.J.; Kaneko, Y.; Kozbor, D. J. Virology, 2000, 267, 8-16.
44. Lavelle, E.C. Crit. Rev. Ther. Drug Carrier Sys., 2001, 18(4), 341-386.
45. Taira, M.C.; Chiaramoni, N.S.; Pecuch, K.M.; Alonso-Romanowski, S. Drug Delivery, 2004, 11, 123-128.
46. Mathiowitz, E.; Jacob, J.S.; Jong, Y.S.; Carino, G., P.; Chickering, D.E.; Chaturvedi, P.; Santos, C.A.; Vijayaraghavan, K.; Montgomery, S.; Bassett, M.; Morrell, C. Nature, 1997, 386, 410-444.
47. Jones, D.H.; Partidos, C.D.; Steward, M.W.; Farrar, G.H.; Behring. Inst. Mitt., 1997, 98, 220-228.
48. Jepson, M.A.; Clark, M.A.; Foster, N.; Mason, C.M.; Bennett, M.K.; Simmons, N.L.; Hirst, B.H. J. Anat., 1996, 189, 507-516.
49. Chen, S.C.; Jones, D.H.; Fynan, E.F.; Farrar, G.H.; Clegg, J.C.S. J. Virology, 1998, 72(7), 5757-5761.
50. Hejazi, R.; Amiji, M. J. Controlled Release, 2003, 89, 151-165.
51. Whan L.J.; Han Park, J.; Robinson, J.R. J. Pharm. Sci., 2000, 89(7), 850-866.
52. Roy, K.; Mao, H.Q.; Huang, S.K.; Leong, K.W. Nature Med., 1999, 5(4), 387-391.
53. Kai, E.; Ochiya, T. Pharm. Res., 2004, 21(5), 838-843.
54. Hussain, N.; Jaitley, V.; Florence, A.T. Adv. Drug Deliv. Rev., 2001, 50, 107-142.
55. Kabouridis, P.S. Trends Biotechnol., 2003, 21(11), 498-503.
56. Wadia, J.S.; Dowdy, S.F. Curr. Opin. Biotechnol., 2002, 13, 52-56.
57. Schwarze, S.R.; Ho, A.; Vocero-Akbani, A.; Dowdy, S.F. Science, 1999, 285, 1569-1572.
58. Hussain, N.; Florence, A.T. Pharm. Res., 1998, 15(1), 153-156.
59. Florence, A.T.; Hussain, N. Adv. Drug Deliv. Rev., 2001, 50, S69-S89.
60. Dawson, G.; Halbert, G. W. Pharm. Res., 2000, 17(11), 420-425.
61. Florence, A.T. J. Drug Targeting, 2004, 12(2), 65-70.
62. Schulte, R.; Wattiau, P.; Hartland, E.L.; Robins-Browne, R.M.; Cornelis, G.R. Infect. Immun., 1996, 64(6), 2106-2113.
63. Autenrieth, I.; Firshing, R. J. Med. Microbiol., 1996, 44, 285-294.
64. Fortineau, N.; Beretti, J.L.; Berche, P.; Simonet, M. Clinical and Diagnostic Laboratory Immunology, 1994, 1(2), 235-237.
65. van den Berg, T.K.; van der Ende, M.; Dopp, E.A.; Kraal, G.; Dijkstra, C.D. Am. J. Pathol., 1993, 143, 1098-1110.
66. Finstad, C.L.; Yi Wang, C.; Kowalski, J.; Zhang, M.; Lei Li, M.; Mao Li, X.; Guo Xia, W.; Bosland, M.C.; Murthy, K.K.; Walfield, A.M.; Koff, W.C.; Zamb, T.J. Vaccine, 2004, 22, 1300-1313.